SAFE vs Convertible Loan Agreement — What Founders Should Know

What SAFE and CLA have in common

Both SAFE and convertible loan are deferred-pricing instruments: the investor transfers money now, and the amount converts into shares later — typically at a qualified financing round — instead of being priced immediately. They allow an early-stage company to raise capital without setting a formal valuation at a moment when valuation is difficult or contentious.

Both can include a valuation cap and a discount, both defer the share price to a future round, and both avoid the complexity of a full share purchase agreement at the seed stage. The differences, however, are significant.

How a SAFE works

A SAFE (Simple Agreement for Future Equity) is not a loan. The investor pays money in exchange for the right to receive shares in a future equity round. There is no maturity date, no interest, and typically no repayment obligation — if no conversion event occurs, the investor simply waits.

Conversion usually happens at a qualified financing (a round above a defined minimum), at the lower of the valuation cap or the round price (usually with a discount). Some SAFE variants include a pro-rata side letter or a most-favored-nation (MFN) clause.

How a convertible loan works

A convertible loan agreement (CLA) is a loan that may convert into shares at a future event. Unlike a SAFE, it is a debt instrument: it has a principal, interest, a maturity date, and often security or seniority. If conversion does not occur by maturity, the investor may be entitled to repayment.

Conversion typically occurs at a qualified financing, at the lower of the valuation cap (with a discount) or the round price. The loan may also convert at maturity, on a sale of the company, or on an event of default — each defined in the agreement.

Key differences side by side

• Legal nature: SAFE is a right to future equity; a CLA is debt that may convert.
• Maturity: SAFE has no maturity; a CLA has a maturity date.
• Interest: SAFE has none; a CLA usually accrues interest.
• Repayment: SAFE is not repayable; a CLA may require repayment at maturity.
• Security: SAFE is typically unsecured; a CLA may be secured or have seniority.
• Default: SAFE has no default-driven acceleration; a CLA may accelerate on events of default.
• Speed: SAFE is faster and simpler; a CLA is more negotiated but more protective for the investor.

In practice, SAFE is the instrument of choice for very early, small, fast rounds, while a CLA is used when the investor wants debt-like protection, a maturity backstop, or when the round is larger and the investor has more leverage.

Terms that actually matter

Regardless of instrument, a few terms drive almost all of the economic and legal impact:

• Valuation cap — the maximum valuation at which the investment converts; a lower cap means more shares for the investor.
• Discount — the percentage reduction applied to the round price at conversion.
• Qualified financing — the threshold that triggers conversion; too low and a tiny round converts the instrument.
• Maturity and conversion at maturity (CLA only) — what happens if no round occurs in time.
• Pro-rata rights — whether the investor can participate in the next round.
• MFN clause — whether the investor gets the benefit of better terms granted to later investors.
• Information rights — whether the investor receives periodic updates.

A cap that is too low, a discount that is too high, or a qualified-financing threshold that is too small can all cause surprises at the priced round. Each term should be understood, not just accepted.

When to choose which

Choose a SAFE when speed and simplicity matter most — typically at the earliest stage, with investors who accept the deferred-pricing model without requiring debt protection. SAFEs are common in pre-seed and accelerator contexts.

Choose a convertible loan when the investor requires a maturity backstop, interest, security, or the ability to be repaid if conversion does not occur. CLAs are more common in slightly later rounds, with institutional investors, or when the investor wants downside protection.

What to negotiate before signing

Before signing either instrument, the founder should understand the cap, the discount, the qualified financing threshold, the maturity (for a CLA), and the conversion mechanics. Each of these can be negotiated, and small changes can have a large effect at the priced round.

It is also important to track all outstanding instruments together. Multiple SAFEs with different caps can produce a cap table that surprises everyone at the next round. Maintaining a model of the fully diluted cap table — including all converts — is essential.

If you have received a SAFE or CLA to sign, reviewing it before signing — not after — is strongly recommended. The Investment Agreements service covers this end to end.